Adenosine, inflammation and asthma--a review

Asthma is a chronic inflammatory condition affecting the airways, with multiple mediators contributing to its pathophysiology. Adenosine, a nucleoside with diverse biological functions, has been identified as a potential player in respiratory diseases. Prior research has shown that adenosine interacts with various immune cells and receptors, influencing inflammation. However, the specific role of adenosine in asthma remains unclear. Elevated adenosine levels in bronchoalveolar lavage fluid of asthmatic patients suggest a possible link to disease progression. This gap motivated further investigation into how adenosine might contribute to asthma mechanisms. No prior work had resolved the dual pro- and anti-inflammatory effects of adenosine in asthma. Understanding these interactions could provide new insights into asthma pathophysiology.

The purpose of this review is to examine the role of adenosine in asthma and inflammation. It focuses on how adenosine affects airway function and immune cell activity. The study aims to clarify the mechanisms through which adenosine may influence asthma symptoms. By analyzing interactions with mast cells and basophils, the review seeks to identify potential therapeutic implications. The specific problem addressed is the lack of consensus regarding adenosine's role in asthma. The motivation stems from clinical observations of elevated adenosine levels in asthmatic patients. This review does not propose new treatments but highlights current evidence. It synthesizes findings to guide future research directions.

This review approach involves analyzing existing literature on adenosine and asthma. The authors synthesized data from studies on adenosine receptors and immune cell interactions. They focused on bronchoalveolar lavage fluid measurements and bronchoconstrictor effects. The methodology includes a critical evaluation of adenosine's effects on mast cells and basophils. The authors compared findings from in vitro and in vivo studies. They examined how adenosine modulates inflammation and antioxidant enzymes. The review also considered the bronchoconstrictor effect of adenosine in asthmatic airways. The synthesis of evidence aimed to clarify the dual pro- and anti-inflammatory roles of adenosine.

The strongest finding is that adenosine levels are elevated in bronchoalveolar lavage fluid of asthmatics. Adenosine interacts with mast cells and basophils, which are key players in allergic inflammation. Studies show that adenosine can both promote and suppress inflammatory responses. The bronchoconstrictor effect of adenosine is well-documented in asthmatic patients. Adenosine receptors on immune cells modulate cytokine release and mediator production. The review highlights that adenosine can influence antioxidant enzyme activity. The dual effects of adenosine suggest a complex regulatory role in asthma. These findings suggest that adenosine may contribute to both asthma symptoms and protective mechanisms.

The authors conclude that adenosine has a multifaceted role in asthma pathophysiology. The evidence suggests that adenosine can both exacerbate and mitigate inflammation. The bronchoconstrictor effect of adenosine is a key finding in asthmatic airways. The interaction with mast cells and basophils is central to its effects. The dual pro- and anti-inflammatory actions of adenosine are well-supported by the literature. The authors propose that adenosine's effects depend on receptor subtype activation. The review highlights the need for further research into adenosine receptor subtypes. The synthesis of findings supports the idea that adenosine may be a therapeutic target in asthma.